Table: Modalis Therapeutics - 6-MTH group results

Modalis Therapeutics

05/08/2021 07:00

Aug 5 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1 mln              337 mln                    
                   (-99.7 pct)                                      
  Operating       loss 477 mln           38 mln                     
  Recurring       loss 464 mln           29 mln                     
  Net                17 mln              26 mln                     
                   (-34.1 pct)                                      
  EPS               0.62 yen            1.07 yen                    
  EPS Diluted       0.59 yen                                        
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T